Deerfield Beach, FL -- (SBWIRE) -- 04/21/2017 -- The global Melanoma Therapeutics market has witnessed an unprecedented boost in market size, owing to a dynamically evolving nature of melanoma treatments over the past few years. The high demand of novel early stage and advanced melanoma therapies along with a booming patient base, has created an impending need for better therapies in the melanoma market. Although, a plethora of treatment options are available today, several immunotherapy's and combination therapies are expected to enter the market. Large uptake of these novel treatments is expected due to their improved survival benefits and minimal side effects. Additionally, untapped patient population, especially, in the Europe and U.S. would lead to a higher uptake of novel treatments in the near future.

Get Free Sample Report Of Melanoma Therapeutics Market @ http://www.marketresearchstore.com/report/world-melanoma-therapeutics-market-opportunities-and-forecasts-71678#RequestSample

According to the skin cancer foundation, an estimated total of 73,870 new diagnosed cases of melanoma are expected in 2015. With an expected death toll of 9,940 cases, melanoma would account for the majority of skin cancer deaths in 2015.

A strong emerging pipeline, rising incidences of melanoma cases and the increasing public awareness are the major factors driving the melanoma market. In addition, the growing interest of physicians towards novel therapies would fuel the market. Conversely, high costs incurred due to combination treatments and limited reimbursement is likely to curtail the market growth.

For companies like Bristol Myers Squibb (BMS), apposite product positioning of novel treatments in order to avoid cannibalization of marketed products would be a key challenge to sustain in the melanoma market.

Do Inquiry To Buy Report Of Melanoma Therapeutics Market @ http://www.marketresearchstore.com/report/world-melanoma-therapeutics-market-opportunities-and-forecasts-71678#InquiryForBuying

The Global Melanoma Therapeutics market segmentation is illustrated below:

Melanoma Therapeutics Market By Therapy Type

Chemotherapy
Biologic therapy
Targeted therapy
Radiation therapy
Surgery
Other novel therapies (Virus based, Adjuvant therapy etc.)

Melanoma Therapeutics Market By Stages

Stage 0 (Melanoma in Situ)
Stage I
Stage II
Stage III
Stage IV

Melanoma Therapeutics Market By Geography

North America

United States
Canada
Mexico

Europe

U.K
Germany
France
Rest of Europe

Asia-Pacific

Japan
Australia
Rest of Asia

LAMEA

Latin America
Middle East and Africa

About Market research Store
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:
Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@marketresearchstore.com
Web: http://www.marketresearchstore.com/